Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC M&A Activity 2021

May 19, 2021

5250_rns_2021-05-19_1ab6d937-ec33-40a8-a7e5-bef3c99571ea.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

FORM 8.3 - WILLIS TOWERS WATSON PLC - AMENDMENT

FORM 8.3

Amendment to sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 17 May 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,659,544 1.29% 172,205 0.13%
(2) Derivatives (other than options):
72,359 0.06% 0 0.00%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
(4) TOTAL:
1,738,003 1.35% 178,305 0.14%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 1 265.5400 USD
Purchase 1 265.1700 USD
Purchase 3 264.8500 USD
Purchase 4 265.9700 USD
Purchase 16 265.8600 USD
Purchase 45 264.6404 USD
Purchase 77 265.0900 USD
Purchase 87 265.0800 USD
Purchase 110 266.0722 USD
Purchase 255 264.3900 USD
Purchase 310 265.8340 USD
Purchase 600 265.9341 USD
Purchase 1,300 265.8131 USD
Purchase 2,395 266.0000 USD
Purchase 2,468 265.6259 USD
Purchase 3,411 265.9574 USD
Purchase 7,240 265.5233 USD
Purchase 21,948 265.7986 USD
Purchase 141,339 265.8244 USD
Sale 2 265.5400 USD
Sale 8 266.2000 USD
Sale 8 266.0700 USD
Sale 8 266.1800 USD
Sale 20 265.8820 USD
Sale 22 265.9209 USD
Sale 24 266.1700 USD
Sale 40 266.0500 USD
Sale 100 265.3700 USD
Sale 100 265.8700 USD
Sale 151 266.1961 USD
Sale 200 265.7300 USD
Sale 235 265.7396 USD
Sale 249 266.2220 USD
Sale 255 264.3900 USD
Sale 300 266.0833 USD
Sale 300 265.7850 USD
Sale 337 266.3002 USD
Sale 394 265.0424 USD
Sale 455 265.5546 USD
Sale 500 265.8350 USD
Sale 550 266.0600 USD
Sale 932 265.7825 USD
Sale 1,300 265.8131 USD
Sale 1,400 265.5300 USD
Sale 1,436 266.0863 USD
Sale 1,522 265.9994 USD
Sale 1,535 265.5308 USD
Sale 1,555 265.5679 USD
Sale 1,721 265.6936 USD
Sale 1,780 265.7926 USD
Sale 1,884 266.0000 USD
Sale 1,936 265.5073 USD
Sale 1,995 265.3468 USD
Sale 2,502 265.5930 USD
Sale 2,550 265.7318 USD
Sale 2,811 265.9374 USD
Sale 5,164 265.4251 USD
Sale 17,645 265.7600 USD
Sale 23,817 265.9255 USD
Sale 24,905 265.7018 USD
Sale 80,159 265.8776 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 19 May 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210519005710/en/

BARCLAYS PLC